BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Sangamo Therapeutics Announces U.S. FDA Clearance of IND Application for ST-503 for the Treatment of Idiopathic Small Fiber Neuropathy, a Type of Chronic Neuropathic Pain

  November 19, 2024

   · 

  6 min read
• Press Releases

  Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model

  November 19, 2024

   · 

  7 min read
• Press Releases

  Lilly announces changes on board of directors

  November 19, 2024

   · 

  3 min read
• Press Releases

  GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover

  November 19, 2024

   · 

  4 min read
• Press Releases

  Kaida BioPharma Announces Formation of Scientific Advisory Board to Support Development of KAD101 for Ovarian Cancer

  November 19, 2024

   · 

  3 min read
• Press Releases

  Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares

  November 19, 2024

   · 

  3 min read
• Press Releases

  Radon Medical Imaging Announces Acquisition of Alpha Imaging

  November 19, 2024

   · 

  5 min read
• Press Releases

  Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line

  November 19, 2024

   · 

  2 min read
• Press Releases

  Uvax Bio Announces Interim Results from a Phase 1 Clinical Trial Evaluating its HIV-1 Vaccine

  November 19, 2024

   · 

  5 min read
• Press Releases

  Lilly Canada remains steadfast in commitment to access options for patients amidst controversial CDA-AMC recommendation for Ebglyss™ (lebrikizumab)

  November 19, 2024

   · 

  5 min read